OVERVIEW

Moving Beyond Factor: Shifting the Paradigm in Hemophilia Through Gene Therapy is organized by National Hemophilia Foundation (NHF).

CME / ABIM MOC Released: 12/20/2019
Valid for credit through 12/20/2020

Description:
This activity features an international panel of experts that review the science underlying therapy strategies, provide updates on the latest data for therapies in development, and critically evaluate the potential role gene therapy may play in patient care, both now and in the future. It is intended for hematologists, pediatric hematologists, and all members of the clinical care team involved in the care of patients with hemophilia. This content was originally presented as a live pre-conference symposium at the 61st American Society of Hematology Annual Meeting & Exposition in December of 2019.

Learning Objective:
Upon completion of this activity, participants will:
• Have increased knowledge regarding the
• Most current safety and efficacy data for emerging gene therapy options in hemophilia
• Have greater competence related to
• Identifying the role of gene therapy in an evolving treatment paradigm

Additional details will be posted as soon as information is available.